Recent upgrades from BofA Securities and KeyBanc have put fresh attention on Schrödinger (SDGR), as the company moves away from expensive in-house drug development and focuses more on its higher ...
Schrödinger, Inc. (NASDAQ:SDGR) is one of the best healthcare AI stocks to buy now. On December 15, BofA Securities upgraded Schrödinger, Inc. (NASDAQ:SDGR) from Neutral to Buy, with a $24 price ...
Schrödinger delivered strong Q1 results, with robust software growth and improving margins, despite a tough macro environment. Regulatory changes, especially the FDA's move away from animal testing, ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results